Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to $171.5 million.

  • Astera Labs' Change in Acquisitions & Divestments rose 37059.24% to $171.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $646.2 million, marking a year-over-year increase of 41690.38%. This contributed to the annual value of $208.7 million for FY2024, which is 8762.48% up from last year.
  • As of Q3 2025, Astera Labs' Change in Acquisitions & Divestments stood at $171.5 million, which was up 37059.24% from $152.2 million recorded in Q2 2025.
  • Astera Labs' 5-year Change in Acquisitions & Divestments high stood at $191.4 million for Q1 2025, and its period low was $9.0 million during Q3 2023.
  • In the last 3 years, Astera Labs' Change in Acquisitions & Divestments had a median value of $45.1 million in 2023 and averaged $75.9 million.
  • As far as peak fluctuations go, Astera Labs' Change in Acquisitions & Divestments plummeted by 5013.31% in 2024, and later surged by 75147.46% in 2025.
  • Over the past 3 years, Astera Labs' Change in Acquisitions & Divestments (Quarter) stood at $47.4 million in 2023, then skyrocketed by 176.35% to $131.1 million in 2024, then skyrocketed by 30.83% to $171.5 million in 2025.
  • Its last three reported values are $171.5 million in Q3 2025, $152.2 million for Q2 2025, and $191.4 million during Q1 2025.